Paula N. Friedman
- Oncology top 0.5%
- HER2/EGFR in Cancer Research 9
- Cancer-related Molecular Pathways 9
- Colorectal Cancer Treatments and Studies 6
- Biotechnology top 0.5%
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 5
- Molecular Biology top 5%
- RNA modifications and cancer 6
- Genetics top 5%
-
- Hepatitis B Virus Studies 7
-
- Hepatitis C virus research 7
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Carol PrivesJill BargonettiBert VogelsteinScott E. KernArthur M. BruskinKenneth W. KinzlerHua ZhuGeorge E. Farmer
- Cited by
- OncologyBiotechnologyCancer Research
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Paula N. Friedman
58 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 3.1k
- Biotechnology 776
- Cancer Research 679
- Molecular Biology 2.4k
- Genetics 465
Countries citing papers authored by Paula N. Friedman
This map shows the geographic impact of Paula N. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula N. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula N. Friedman more than expected).
Fields of papers citing papers by Paula N. Friedman
This network shows the impact of papers produced by Paula N. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula N. Friedman. The network helps show where Paula N. Friedman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paula N. Friedman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2020 | 25 | |
| 4 | 2016 | 35 | |
| 5 | 2015 | 8 | |
| 6 | 2013 | 117 | |
| 7 | 2013 | 82 | |
| 8 | 2013 | 1 | |
| 9 | 2012 | 160 | |
| 10 | 2007 | 190 | |
| 11 | 2005 | 24 | |
| 12 | 2003 | 3 | |
| 13 | 2002 | 21 | |
| 14 | 1999 | 10 | |
| 15 | 1998 | 54 | |
| 16 | 1998 | 12 | |
| 17 | 1993 | 17 | |
| 18 | 1992 | 1 | |
| 19 | 1991 | 10 | |
| 20 | 1991 | 327 |
About Paula N. Friedman
Paula N. Friedman is a scholar working on Oncology, Hepatology and Internal Medicine, having authored 62 papers that have together received 4.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Cancer-related Molecular Pathways (9 papers), Hepatitis B Virus Studies (7 papers), Hepatitis C virus research (7 papers), Colorectal Cancer Treatments and Studies (6 papers), RNA modifications and cancer (6 papers), Cancer Genomics and Diagnostics (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Oncology (3.1k citations), Biotechnology (776 citations) and Cancer Research (679 citations). Paula N. Friedman has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Carol Prives, Jill Bargonetti, Bert Vogelstein, Scott E. Kern, Arthur M. Bruskin, Kenneth W. Kinzler, Hua Zhu, George E. Farmer, Ron Prywes and D R Marshak. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.